Literature DB >> 9869212

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients.

Z X Zhang1, X Z Gu, W B Yin, G J Huang, D W Zhang, R G Zhang.   

Abstract

PURPOSE: An attempt was made to define the role of radiotherapy before operation for AGC. METHODS AND MATERIALS: From January 1978 to May 1989, a prospective randomized trial on preoperative radiotherapy (R+S) vs. surgery alone (S) for AGC was carried out in 370 patients. Patients were randomized into a combined group (R+S, 171 patients) or a surgery alone group (S, 199 patients) by the envelope method. 8-MV photon or telecobalt was used for the preoperative radiation therapy, using anterior-posterior opposing parallel fields to deliver 40 Gy to the cardia, lower segment of the esophagus, fundus, lesser curvature, and hepatogastric ligament. Surgery was performed after 2 to 4 weeks rest.
RESULTS: The 5- and 10-year survival rates of the R+S Group and the S Alone Group were 30.10% and 19.75%, 20.26% and 13.30%, respectively. The survival curves of these two groups diverged right from the beginning after the operation over the ninth year. Statistics by Kaplan-Meier log rank test proves that the difference is significant (chi2 = 6.74, p = 0.0094). The immediate results were: resection rate 89.5% and 79.4% (p < 0.01); pathologic stage after resection T2 12.9% and 4.5% (p < 0.01), T4 40.3% and 51.3% (p < 0.05), lymph node metastasis rates 64.3% and 84.9% (p < 0.001); operative mortality rates 0.6% and 2.5%; intrathoracic leak rates 1.8% and 4.0%, respectively. The causes of failure were: local uncontrol and recurrence 38.6% vs. 51.7% (p < 0.025), regional lymph node metastasis 38.6% vs. 54.6% (p < 0.005), distant metastasis 24.3% vs. 24.7%.
CONCLUSION: Preoperative radiation therapy is able to improve the results of surgery for adenocarcinoma of the gastric cardia.

Entities:  

Mesh:

Year:  1998        PMID: 9869212     DOI: 10.1016/s0360-3016(98)00280-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  79 in total

1.  Neoadjuvant chemotherapy for locally advanced gastric cancer: With or without radiation.

Authors:  Ai-Wen Wu; Jia-Fu Ji
Journal:  World J Gastrointest Surg       Date:  2012-02-27

2.  Evidence based radiation therapy for locally advanced resectable and unresectable gastric cancer.

Authors:  Georgios V Koukourakis
Journal:  World J Gastrointest Oncol       Date:  2011-09-15

Review 3.  Updating controversies on the multidisciplinary management of gastric cancer.

Authors:  Javier Lacueva; Javier Gallego; Juan Antonio Díaz-González
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

4.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

5.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

6.  A cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gastric cancer.

Authors:  Samuel J Wang; Clifton D Fuller; Mehee Choi; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2008-03

Review 7.  Radiotherapy for gastric cancer: a systematic review and meta-analysis.

Authors:  Xiaohui Pang; Wanqing Wei; Weibing Leng; Qi Chen; Hongwei Xia; Liu Chen; Ronghui Li
Journal:  Tumour Biol       Date:  2013-08-09

8.  Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin.

Authors:  Kaoru Takabayashi; Kazuhiro Kashiwagi; Tetsuya Kawata; Toshiro Sato; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Hiromasa Takaishi; Toshifumi Hibi; Haruhiko Ogata; Naohisa Yahagi; Yuko Kitagawa; Naoyuki Shigematsu; Takanori Kanai
Journal:  Cancer Biol Ther       Date:  2013-10-22       Impact factor: 4.742

Review 9.  Treatment of gastric cancer.

Authors:  Michele Orditura; Gennaro Galizia; Vincenzo Sforza; Valentina Gambardella; Alessio Fabozzi; Maria Maddalena Laterza; Francesca Andreozzi; Jole Ventriglia; Beatrice Savastano; Andrea Mabilia; Eva Lieto; Fortunato Ciardiello; Ferdinando De Vita
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 10.  Current adjuvant treatment modalities for gastric cancer: From history to the future.

Authors:  Leyla Kilic; Cetin Ordu; Ibrahim Yildiz; Fatma Sen; Serkan Keskin; Rumeysa Ciftci; Kezban Nur Pilanci
Journal:  World J Gastrointest Oncol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.